"Cenas e coisas" que dizem que fazem bem (ou mal). Agregador de algumas notícias relacionadas com saúde. Os "disclaimers" habituais e mais alguns aplicam-se: O uso da informação aqui veiculada é por conta e risco de cada um. Consulte-se um médico ou nutricionista (conforme o caso) antes de adotar alguma medida ou informação directa ou indirectamente publicada ou veiculada.
Mostrar mensagens com a etiqueta MS. Mostrar todas as mensagens
Mostrar mensagens com a etiqueta MS. Mostrar todas as mensagens
quarta-feira, 25 de julho de 2018
Resultados da M$
http://exameinformatica.sapo.pt/noticias/mercados/2018-07-20-Surface-e-setor-de-gaming-elevam-receitas-trimestrais-da-Microsoft
quinta-feira, 9 de junho de 2016
Mutação de gene associada a certo tipo de Esclerose Múltipla
http://www.bbc.com/news/health-36416531
Citando:
"The mutation is in a gene called NR1H3, which makes a protein that acts as a switch controlling inflammation.
In MS the body's immune system mistakenly attacks the protective layer of myelin that surrounds nerve fibres in the brain and spinal cord, leading to muscle weakness and other symptoms."
(...)
"The researchers believe stopping the inflammation early might prevent or delay the disease. They already have drugs in mind that might do this by targeting the NR1H3 gene pathway.
These drugs are in development for other diseases, including cardiovascular disease and diabetes."
(...)
"[This MS] variant itself is rare and most people with MS won't have it. "
Citando:
"The mutation is in a gene called NR1H3, which makes a protein that acts as a switch controlling inflammation.
In MS the body's immune system mistakenly attacks the protective layer of myelin that surrounds nerve fibres in the brain and spinal cord, leading to muscle weakness and other symptoms."
(...)
"The researchers believe stopping the inflammation early might prevent or delay the disease. They already have drugs in mind that might do this by targeting the NR1H3 gene pathway.
These drugs are in development for other diseases, including cardiovascular disease and diabetes."
(...)
"[This MS] variant itself is rare and most people with MS won't have it. "
Parar a esclerose múltipla? - Estudo / Tratamento
http://www.bbc.com/news/health-36490315
Citando:
"The condition causes the immune system to attack the lining of nerves in the brain and spinal cord. Most patients are diagnosed in their 20s and 30s.
One existing treatment is for the immune system to be suppressed with chemotherapy and then stem cells are introduced to the patient's bloodstream - this procedure is known as an autologous haematopoietic stem cell transplant (HSCT).
(...)
But in this study, Canadian researchers went further - not just suppressing the immune system, but destroying it altogether.
It is then rebuilt with stem cells harvested from the patient's own blood which are at such an early stage, they have not developed the flaws that trigger MS.
The authors said that among the survivors, over a period of up to 13 years, there were no relapses and no new detectable disease activity."
(...) "1 person died".
Citando:
"The condition causes the immune system to attack the lining of nerves in the brain and spinal cord. Most patients are diagnosed in their 20s and 30s.
One existing treatment is for the immune system to be suppressed with chemotherapy and then stem cells are introduced to the patient's bloodstream - this procedure is known as an autologous haematopoietic stem cell transplant (HSCT).
(...)
But in this study, Canadian researchers went further - not just suppressing the immune system, but destroying it altogether.
It is then rebuilt with stem cells harvested from the patient's own blood which are at such an early stage, they have not developed the flaws that trigger MS.
The authors said that among the survivors, over a period of up to 13 years, there were no relapses and no new detectable disease activity."
(...) "1 person died".
Subscrever:
Mensagens (Atom)